Our results revealed that LINC00909, ELOA-AS1, and LINC00515 expressions were obviously increased in the tumors of serous, endometrioid, and clear-cell ovarian cancers when compared with that in normal ovarian tissues (Figure 3(a) and S1A). The gene discussed is ELOA; the disease is ovarian clear cell cancer.